Community outreach to prevent cancer in teens and young adults
Outreach Core
This project brings proven cancer-prevention programs into underserved adolescents and young adults to help reduce tobacco and alcohol use, support healthy weight, and increase HPV vaccination.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11162265 on NIH RePORTER |
What this research studies
If you're a teen or young adult in Greater Boston, this project works with local community groups to bring proven cancer-prevention programs to your neighborhood. A Community Advisory Board that includes young people will help shape and adapt programs so they fit local needs and culture. The team trains and supports community organizations to deliver evidence-based activities aimed at reducing risk behaviors and increasing vaccination. Participation may involve meeting with local groups, receiving services or education at community sites, or helping guide how programs are run.
Who could benefit from this research
Good fit: Adolescents and young adults (about ages 12–20) in Greater Boston or Greater Lawrence, MA, especially those from underserved communities, are the intended participants.
Not a fit: People outside the target age range, living outside the catchment areas, or not reached by participating community organizations may not receive direct benefit.
Why it matters
Potential benefit: If successful, this work could lower future cancer risk by helping AYAs avoid tobacco and alcohol, maintain healthy weight, and increase HPV vaccine uptake.
How similar studies have performed: Evidence-based prevention programs have reduced tobacco use and increased HPV vaccination in some settings, but adapting them for underserved AYAs through community outreach is still being refined.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Ramanadhan, Shoba — Dana-Farber Cancer Inst
- Study coordinator: Ramanadhan, Shoba
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.